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Urodynamic studies (UDSs) encompass a series of clinical tests, such as uroﬂowmetry, ﬁlling cystometry,
pressure-ﬂow studies and assessment of urethral closure (including urethral pressure proﬁlometry and
measurement of the leak-point pressure). Lower urinary tract symptoms are not alwayswell correlatedwith
the results of UDSs. Such studies are indicated in the following situations: (1) when conservative treatment
is ineffective; (2) when invasive treatment is being considered; (3) for protection of the upper urinary tract
by creating a low-pressure reservoir and control of urinary incontinence; (4) for evaluation of the effects of
treatment; and (5) for biofeedback training. Video urodynamics is described as the gold standard of
conventional UDSs. Characteristic features of various types of lower urinary tract symptoms, including
urinary incontinence, bladder outlet obstruction and neurogenic bladder, can be identiﬁed by UDSs.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Urodynamic studies (UDSs) involve the investigation of urinary
tract function/dysfunction by various methods,1,2 such as uro-
ﬂowmetry, ﬁlling cystometry (CMG), pressure-ﬂow studies, and
assessment of urethral closure [including urethral pressure proﬁl-
ometry and measurement of the leak-point pressure (LPP)]. These
tests can be combined with simultaneous electromyography and/or
imaging.3 Video urodynamics are the gold standard investigation
for patients with lower urinary tract symptoms (LUTSs).32. Indications for urodynamic studies
UDSs provide objective information on the occurrence of LUTSs
and enable determination of a person’s lower urinary tract (LUT)
performance in relation to what is known about normal or
abnormal urinary tract physiology.4
The most important target when treating LUT dysfunction is
alleviating LUTSs. LUTSs may be related to a variety of pathophys-
iological processes, however, and assessment on the basis of
symptoms alone often leads to an incorrect diagnosis, especially in
patients with a neurogenic bladder. It is therefore necessary tokkyo Medical University, 880
manishi).
ciation. Published by Elsevier Taiwobtain objective data to make an accurate diagnosis, although
LUTSs are not always well correlated with the diagnosis provided
by UDSs. For example, there is only a weak association between the
LPP and the severity of symptomatic or measured urinary incon-
tinence (UI) and a weak correlation between symptoms and results
of UDSs (especially cystometry) in patients with UI.5,6
Uroﬂowmetry and measurement of post-voiding residual urine
by ultrasonography are noninvasive tests that can be routinely
performed in patients with LUTSs. The other UDSs are invasive tests
and therefore should only be performed in selected cases.
UDSs are indicated is the following circumstances: (1) when
conservative treatment is ineffective; (2) when invasive treatment
is being considered; (3) for protection of the upper urinary tract by
creating a low-pressure reservoir and for controlling UI; (4) for
evaluation of the effects of treatment; and (5) for biofeedback
training.7 It is important for investigators and clinicians to evaluate
the results of UDSs in relation to each patient’s symptoms, and to
interpret the ﬁndings obtained by such tests in relation to symp-
toms, data from the voiding diary, and results of clinical (or other)
examinations.3
2.1. Conventional urodynamic studies
Conventional UDSs involve artiﬁcial ﬁlling of the bladder. CMG
can be performed using either gas or water. Although the gas
method can provide an acceptable alternative to other techniques
for measuring pressures, no studies have determined whetheran LLC. Open access under CC BY-NC-ND license.
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measuring intravesical and intra-abdominal pressures.1 Accord-
ingly, CMG (including pressure-ﬂow study) with a water-ﬁlled
catheter is recommended for conventional UDSs. However, it is
unknown whether this improves the reproducibility, sensitivity
and speciﬁcity of UDSs.3
Conventional UDSs have been criticized for being non-
physiological tests, and there is disagreement between the urody-
namic and symptom-based diagnoses in 19e44% of patients.8,9
Inter-institutional variation and inter-observer variation have
been reported for conventional UDSs.10e14 With regard to short-
term (within test), intermediate and long-term reproducibility of
UDSs, a testeretest variation of 10e15% for various volume, pres-
sure or ﬂow parameters is regarded as being due to physiological
variations.10
There are various methods for performing conventional UDSs,
and our laboratory uses the following method. After free ﬂowmetry,
a thin (e.g., 57 Fr) double-lumen catheter is inserted transur-
ethrally for ﬁlling and pressure recording, and water CMG is per-
formed at an infusion rate of 50 mL/minute (medium ﬁlling) in the
supine position. The intra-abdominal pressure (Pabd) is simulta-
neously measured with a balloon catheter that is inserted trans-
rectally. The detrusor pressure (Pdet) is measured by subtracting
Pabd from the intravesical pressure (Pves). At maximum cystometric
capacity, patients assume a standing position, and provocation tests
(including heel bouncing, coughing and exposure to water) are
carried out. For females with stress UI, Valsalva or cough LPP is
measured by gradually increasing the abdominal pressure (strain-
ing) or by coughing, respectively. Patients then void while standing
on an elevated platform (males) or sitting (females) behind a screen
and pressure-ﬂow studies are carried out (Figure 1).15
2.1.1. External sphincter electromyography
External sphincter electromyography is performed simulta-
neously using surface electrodes or needle electrodes. Surface
electrodes are noninvasive and measure the activity of striatedFigure 1. Video-urodynamic study. Upper left panel, ﬁlling phase; upper right panel, voi
ambulatory urodynamic study.muscles near the electrode sites, but they may measure muscles
other than the external sphincter. Insertion of needle electrodes
may be painful, but such electrodes measure the activity of the
target muscle (i.e., the external sphincter). External sphincter elec-
tromyography can assess the coordination of detrusor and external
sphincter activity, motor unit potency and evoked potentials.16
2.1.2. Ice-water cystometry
Ice-water cystometry can be performed to elicit detrusor
activity in patients with LUT dysfunction and relevant neurological
abnormalities.17,18 Detection of detrusor contractions during ﬁlling
with ice water can be interpreted as a sign of pathological C-ﬁber
reﬂex activity (i.e., only found in patients with the relevant
neurologic conditions), but false-negative results can occur.
2.2. Noninvasive methods
Measurement of pressure and ﬂow in men with a penile cuff or
condom catheter have been reported as noninvasive methods that
are as clinically useful as conventional pressure-ﬂow studies.19e21
Ambulatory urodynamic monitoring (AUM) is a functional
urodynamic test that uses natural ﬁlling and reproduces the
everyday activities of the subject.2,22,23 AUM has the advantages of
natural bladder ﬁlling, a longer observation period and a relatively
normal study environment, and is therefore more physiological
than conventional UDS (Figure 1).8,24 AUM has been reported to
detect detrusor over-activity more accurately than conventional
urodynamics, and there is a strong correlation of symptoms with
AUM ﬁndings.14
3. Interpretation of urodynamic study parameters
3.1. Normal subjects
Studies have been performed to obtain normal values of UDS
parameters in volunteers, including volumes, compliance andding phase in females; lower left panel, voiding phase in males; lower right panel,
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detrusor pressure does not usually increase (it is stable) when the
ﬁrst sensation is noted at 150e250 mL or at the maximum cysto-
metric capacity of 300e500 mL in volunteers.27
Detrusor over-activity (DO) is deﬁned as involuntary detrusor
contractions during the ﬁlling phase, which may be spontaneous or
provoked (Figure 2).2 Detrusor over-activity is found in 10e20% of
healthy volunteers with conventional UDSs. It has been reported
that detrusor over-activity is more common with subjects in the
sitting position compared with those in the supine position during
cystometry.25 Furthermore, there is some evidence that entering
a toilet and hand washing are strong stimulators of detrusor over-
activity.3 Therefore, the position of the patient during ﬁlling cyst-
ometry should be taken into account because it can inﬂuence the
occurrence of detrusor over-activity. The results of provocative
cystometry should be interpreted in relation to the patient’s
symptoms and how reasonable the ﬁndings obtained are. The
incidence of detrusor over-activity has been reported to increase to
30e70% when using AUM.22,24,28e31
During the voiding phase, normal subjects void with good ﬂow
(Qmax > 15 mL/second with a voided volume of >150 mL) and their
detrusor pressure at Qmax (PdetQmax) of 60e90 cm H2O. According
to pressure-ﬂow studies, the International Continence Society (ICS)
nomogram or Shäfer nomogram is within the unobstructed range
in males. In females, however, detrusor pressure is <40 cmH2O
during voiding, and some elderly subjects or patients with stress
incontinence can void without an increase in detrusor pressure
(Figure 3).
4. Classiﬁcation of LUT dysfunction
According to the ICS standards, LUT function is classiﬁed into
detrusor and urethral function or ﬁlling and voiding function.
Therefore, LUT dysfunction is classiﬁed as detrusor over-activity, an
underactive detrusor, or an acontractile detrusor and the presence
of an incompetent or obstructive urethra (Table 1).2
4.1. Bladder outlet obstruction
Male patients with benign prostatic hyperplasia, bladder neck
obstruction or urethral stricture and female patients with bladder
neck obstruction or pelvic organ prolapse may have bladder
outlet obstruction (BOO). During the voiding phase, BOO mayFigure 2. Urodynamic ﬁndingmanifest as a high detrusor pressure with decreased urinary ﬂow
(obstructed pattern ¼ high pressure/low ﬂow pattern) on an ICS
nomogram or Schäfer nomogram obtained by pressure-ﬂow
studies (Figure 4).2 The BOO index, formerly known as the
Abrams-Grifﬁth number (¼PdetQmax  2Qmax), is >40 in patients
with BOO. During the ﬁlling phase, detrusor over-activity may
be detected in 40e60% of patients with benign prostatic
hyperplasia.15,32e34
4.2. Patients with UI
There are threemain types of UI: urge UI, stress UI andmixed UI.
Urge UI is associated with overactive bladder dysfunction (OAB,
also known as wet OAB), and is considered to be related to detrusor
over-activity. Urodynamic stress UI is deﬁned as the involuntary
leakage of urine along with increased abdominal pressure in the
absence of detrusor contraction during the ﬁlling phase. To assess
urethral function during ﬁlling, the urethral pressure proﬁlometry
or (abdominal or detrusor) LPP is measured. UDSs should be per-
formed in women prior to surgical intervention for stress UI.
However, various studies have shown that the results of UDSs do
not precisely predict the response to treatment in patients who
have OABwith or without detrusor over-activity, or in patients with
urodynamic stress UI.35,36 In fact, the association between symp-
toms of OAB and detection of detrusor over-activity during UDS is
weak, and currently it is not possible to predict the response to
treatment on the basis of characterization or quantiﬁcation of
detrusor over-activity during UDS.37
There are conﬂicting results regarding the association between
the severity of UI and the results of urethral function tests (LPP and
urethral closing pressure). Measurements of urethral function (LPP
and urethral pressure proﬁlometry) are not useful for accurately
predicting the likelihood of success after surgical treatment for
stress UI. However, there is some evidence that a low urethral
(closing) pressure is associated with a lower suburethral sling
procedure success rate.38e40
5. Neurogenic bladder (Table 2)
Lesions in the cerebral cortex, the basal ganglia and brain stem,
the spinal cord, conus, or cauda equina and peripheral lesions can
cause various types of neurogenic bladder. Neurogenic detrusor
over-activity is frequently associated with upper motor neurons of detrusor overactivity.
Figure 3. Urodynamic ﬁndings in a normal female who voided without an increase in detrusor pressure. Upper panel, entire study; lower panel, voiding phase.
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(DSD) is frequently found in patients with spinal cord lesions and
less frequently in those with brain stem lesions, but is rare in
patients with cerebral lesions. Underactive or acontractile detrusor
may be present in patients with lower motor neuron lesions
(affecting the lower lumbar cord, conus or cauda equina lesions and
peripheral nerves).41,42Table 1
Classiﬁcation of urinary tract dysfunction (ICS 2002)
Filling phase Voiding phase
Detrusor function DO UAD, ACD
Bladder sensation increased
(hypersensitive), reduced
(hyposensitive)
Urethral function Incompetent Obstructive:
BOO
Dysfunctional voiding
DSD
Non-relaxing
DO ¼ detrusor overactivity; UAD ¼ underactive detrusor; ACD ¼ acontractile
detrusor; BOO ¼ bladder outlet obstruction; DSD ¼ detrusor sphincter dyssynergia.5.1. Urodynamic study ﬁndings in patients with cortical lesions
In general, the most common cystometric ﬁnding is detrusor
over-activity, and a few patients with cortical lesions show DSD. In
our series of 72 patients with acute hemispheric stroke, 53% were
found to have signiﬁcant urinary complaints.43 The most common
problem was nocturnal urinary frequency (36%), followed by UI
(29%) and difﬁculty in voiding (25%). Urinary retention was
observed in 6% of patients during the acute phase of the stroke.
Brain Imaging conﬁrmed amore anterior location of brain lesions in
the former group. UDS showed detrusor over-activity in 79%, a non-
relaxing urethra in 16% and uninhibited sphincter relaxation in 42%
of patients. There was no preponderance of right-sided lesions.43 In
some patients with a particular brain lesion (e.g. small cortical
infarcts in the caudal part of the right anterior cingulate gyrus),
retention of urine probably occurs because of injury to the facili-
tatory region of the brain.44
The classical triad of idiopathic normal pressure hydrocephalus
consists of gait disturbance, memory deﬁcit and UI. In a series of 42
patients with idiopathic normal pressure hydrocephalus, LUTSs
were present in 93% of patients, with storage symptoms (93%)
being more common than voiding symptoms (71%). UDSs showed
Figure 4. Urodynamic ﬁndings and ICS nomogram in bladder outlet obstruction.
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detrusor over-activity was found in 95% of the patients.45
5.2. Urodynamic study ﬁndings in patients with multiple
system atrophy
In patients who have severe LUTSs despite relatively mild
parkinsonism,multiple system atrophy should be considered.41 The
onset of LUTSs in multiple system atrophy may precede overt
neurological involvement by a number of years, with LUTS and
erectile dysfunction occurring 4e5 years prior to a diagnosis and an
average of 2 years before more obvious neurological symptoms
appear.41 Detrusor over-activity and hyperactivity with impaired
contraction are the most common initial UDS ﬁndings.46e49 Over
ensuing months or years, a failure of bladder emptying may
develop due to underactive detrusor/acontractile detrusor or DSD,
where the post-voiding residual urine gradually increases and
urinary retention may occur.48 It has been suggested that detrusor
over-activity is due to loss of cells in the brainstem, whereas
incomplete bladder emptying is due to loss of parasympathetic
stimulation of the detrusor following atrophy of cells in the inter-
mediolateral cell column. In addition to this, anterior horn cell loss
in Onuf’s nucleus results in denervation of the urethral sphincter,
resulting in patients having a combination of detrusor over-
activity/hyperactivity with impaired contraction and a weak
sphincter.41,48 A previous study showed a decrease in cerebellar
vermis activation during urinary storage and micturition, which
was detected by single-photon emission computed tomographic
brain imaging.50
5.3. Urodynamic study ﬁndings in patients with Parkinson’s disease
LUTSs usually arise after many years of treating Parkinson’s
disease and patients often show long-term side-effects of levo-
dopa.41 The most common UDS ﬁnding in Parkinson’s disease
patients is detrusor over-activity, and these patients complain of
OAB symptoms.51,52 In anaesthetized cats, the dopamine D1
receptor is responsible for the main inhibitory effect on the
micturition reﬂex.53 BOO may occur in Parkinson’s disease because
of impaired relaxation or “bradykinesia” of the urethral sphincter.54
When administration of domperidone was followed by subcuta-
neous apomorphine in 10 patients who had Parkinson’s disease andurinary symptoms, it was found that apomorphine reduced bladder
outﬂow resistance and improved voiding in all 10 patients.54
Genitourinary autonomic dysfunction often fails to respond to
levodopa treatment. The neural pathology causing bladder
dysfunction (over-activity) involves alteration of the dopamine
circuit in the basal ganglia, which normally suppresses the mictu-
rition reﬂex. In contrast, hypothalamic involvement is mainly
responsible for sexual dysfunction in Parkinson’s disease (decrease
in libido and erections) due to changes in the dopamineoxytocin
pathway that normally promotes libido and erection. The patho-
physiology of genitourinary dysfunction in Parkinson’s disease
differs from that in multiple system atrophy, and therefore inves-
tigations might be helpful in making a differential diagnosis.55
5.4. Urodynamic study ﬁndings in patients with brainstem lesions
In a study of 39 patients with brainstem strokes, 50% had LUTSs,
with nocturnal frequency and voiding difﬁculty in 28%, urinary
retention in 21% and UI in 8%. LUTSs were more common following
cerebral hemorrhage.56 LUTSs did not occur in patients with
midbrain lesions, but were found in 35% of those with pontine
lesions and 18% of those with medullary stroke. Among 11 symp-
tomatic patients, UDS showed detrusor over-activity in 73%, low-
compliance bladder in 9%, acontractile detrusor in 27% and DSD
in 45%.56
5.5. Urodynamic study ﬁndings in patients with spinal cord disease
Immediately following spinal cord injury and during the
phase of spinal shock, the bladder is acontractile. In patients with
spinal cord disease above the sacral cord (upper motor neuron
involvement), new reﬂexes (detrusor over-activity) develop
without bladder sensation over the course of several weeks.
Disconnection of the pontine micturition centers from the sacral
cord means that synergy between the detrusor and sphincter is
lost, resulting in DSD and detrusor bladder neck dyssynergia
(Figure 5).32,57
With regard to the mechanism of recovery, it was reported that
C ﬁbers emerge as the major afferents in a spinal segmental
reﬂex.41 In patients with lower lumbar spinal cord or cauda equina
lesions (lower motor neuron involvement), the bladder is acon-
tractile, and the urethra is inactive.
Figure 5. Urodynamic ﬁndings in a patient with neurogenic detrusor overactivity and detrusor-sphincter dyssynergia.
Table 2
Urodynamic ﬁndings in neurogenic diseases in our study
Disease DO DO UAD/ACD
DSD () DSD (þ)
Brain lesions
Acute hemispheric stroke (n ¼ 72)58 79 0
iNPH (n ¼ 42)45 95 0 0
Multiple system atrophy (n ¼ 121)46 14 45 36
Parkinson’s disease (n ¼ 39)51 46 3 0
Brainstem stroke (n ¼ 39)56 28 45 36
Non-traumatic spinal cord lesions
Cervical myelopathies (n ¼ 128)58 64 23
Cervical/thoracic disc prolapse (n ¼ 14)59 22 14 7
Anterior spinal artery syndrome (n ¼ 10)60 40 40 10
Tabes dorsalis (n ¼ 8)61 46 36
Amyotrophic lateral sclerosis (n ¼ 36)62 25 22 0
Syringomyelia (n ¼ 14)63 21 29 14
Transverse myelitis (n ¼ 10)64 0 40 0
HAM (n ¼ 5)65 60 40 0
Arteriovenous malformation66 7 33 40
Lumbar disc prolapse (n ¼ 19)67 5 5 26
Lumbar spinal canal stenosis (n ¼ 29)67 31 3 7
Radiation myelopathy (n ¼ 5)69 0 90 10
Brown-Sequard syndrome (n ¼ 8)70 12 38 12
Peripheral lesions
Diabetic mellitus (n ¼ 84)73 42 0 48
CIDP (n ¼ 32)74 50 0 25
Guillain-Barré syndrome (n ¼ 28)75 50 0 25
Values are shown as %.
DO ¼ detrusor overactivity; UAD/ACD ¼ underactive detrusor or acontractile
detrusor; DSD¼ detrusor external sphincter dyssynergia; iNPH¼ idiopathic normal
pressure hydrocephalus; HAM ¼ human T-lymphotropic virus type 1 (HTLV-1)-
associated myelopathy; CIDP ¼ chronic inﬂammatory demyelinating
polyradiculoneuropathy.
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A typical spinal cord disorder is a spinal cord injury. If a patient
has a cord injury above the sacral micturition center (upper motor
neuron involvement), detrusor over-activity occurs with DSD,
while sacral or lower lesions lead to underactive/acontractile
detrusor. Neurogenic detrusor over-activity, loss of compliance and
DSD may cause vesicoureteric reﬂux, hydronephrosis and upper
urinary tract damage.
5.7. Nontraumatic spinal cord diseases
UDS ﬁndings in patients with nontraumatic spinal cord diseases
are similar to those due to traumatic spinal cord injuries, but the
ﬁndings may vary if there is partial spinal involvement (Table 2). In
patients with upper motor neuron involvement, detrusor over-
activity and DSD are the most common urodynamic ﬁndings and
the majority of patients with these abnormalities have long tract
symptoms and signs. In 128 patients with cervical myelopathy,
including 82 with spondylotic myelopathy and 46 with ossiﬁcation
of the posterior longitudinal ligament, storage symptoms were
observed in 64% and voiding symptoms in 75%. In addition, UI was
detected in 26% of patients and post-voiding residual urine of
>100 mL or retention was found in 23%, while UDS revealed
detrusor over-activity in 64% and DSD in 23% of these patients.
Furthermore, a relationship between detrusor over-activity and
pyramidal signswas found in patients with cervical myelopathy.58,59
Among patients with anterior spinal artery syndrome, detrusor
over-activity was observed in 80%, a normal bladder was found in
10% and acontractile detrusor was found in 10% of patients.60
Vesicomotor dysfunction in this syndrome is similar to that of
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preserved.60 In contrast, a previous study observed disturbed
bladder sensation with various types of voiding dysfunction due to
tabes dorsalis.61 From these ﬁndings, the pathway subserving
detrusor function appears to mainly be located in the lateral
column of the spinal cord. The majority of the descending pathway
subserving coordination of the bladder and urethral sphincter
appears be located in the lateral column. Moreover, the path sub-
serving bladder sensation is thought to be located in the dorsal
column of the spinal cord.58e61
Amyotrophic lateral sclerosis is a degenerative neurological
disease inwhich limbweakness, amyotrophy, dysarthria, dysphagia
and respiratory failure develop because of degeneration of motor
neurons. It is thought that amyotrophic lateral sclerosis patients
rarely have LUT dysfunction, and that the anterior horn nucleus
(Onuf’s nucleus) is selectively preserved in this disease. In
a previous study, however, LUTSswere found in 47% of amyotrophic
lateral sclerosis patients, with voiding symptoms in 14%, storage
symptoms in 22% and both types of symptoms in 11% of patients.
Detrusor over-activity was noted in 25% of patients.62
Syringomyelia is cavitation of the spinal cord parenchyma that
can cause progressive spinal cord dysfunction due to expansion of
the central canal. In patients with Arnold-Chiari malformation,
syringomyelia often occurs and LUTSs are found in 9e25% of
patients. In our series of patients, 35% had detrusor over-activity,
including DSD in 14%.63
In patients with transverse myelitis, there may be good clinical
recovery from tetraparesis of such severity that artiﬁcial ventilation
is necessary, and bladder dysfunction may be the sole residual
neurological sequela.64
Human T-lymphotrophic virus type 1-associated myelopathy is
also known as tropical spastic paraparesis and progressive
myelopathy, because of viral infection being observed in British
patients of Caribbean origin and in the Japanese.65 This disease is
a neurological manifestation of infection by the human T-lym-
photrophic virus type 1 retrovirus. Myelopathy slowly progresses
over the course of a decade or more, with its onset usually being
before the age of 40 years. UI due to detrusor over-activity is an
early feature found in most of these patients. A low-compliance
bladder or acontractile detrusor is not found. External sphincter
electromyography shows DSD in 40% of patients, but neurogenic
changes in the motor unit potential are not observed.65
Arteriovenous malformations of the spinal cord may be difﬁcult
to recognize clinically, but disturbance of bladder function is
a prominent early feature in many cases. Although the majority of
arteriovenous malformations occur in the thoracolumbar region,
alterations in cord blood ﬂowand subsequent conus ischemiamean
that the patient may present with what appears to be a conus or
cauda equina lesion.41 Voiding difﬁculties are common at an early
stage and are followed later by urinary retention.66 In 80% of these
patients, abnormalities are revealed by UDSs before treatment,
including detrusor over-activity with or without DSD in 40% and
underactive detrusor in 40% of patients. LUT function only recovers
in 25% of patients after treatment.66
The common urodynamic ﬁndings in patients with lower
lumbar spine lesions, such as intervertebral disc prolapse and
spinal canal stenosis, are underactive or acontractile detrusor, but
detrusor over-activity is also found in 10% of patients with lumbar
disc prolapse and 29% of those with lumbar canal stenosis. In these
patients, urgency, urge UI and, in males, erectile dysfunction are
usually observed in association with intermittent claudication.67
Clinical features of cauda equina syndrome include low back
pain, bilateral sciatica, saddle anesthesia and acute urinary reten-
tion. It typically occurs with central lumbar disc prolapse (the
incidence is 1e5% of all prolapsed lumbar discs). Clinically, there isperineal sensory loss caused by damage to the S2S4 roots together
with loss of voluntary control of both the anal and urethral
sphincters and sexual dysfunction. The detrusor is not denervated,
but is decentralized by cauda equina injury, and sympathetic
innervation of the bladder neck may be preserved.41 In our study of
eight patients, all of them still demonstrated acontractile detrusor
up to 6 years after undergoing emergency surgery within 48 hours.
Bladder function was irreversibly lost despite spinal surgery, while
urethral function showed better recovery in patients with acute
retention because of central lumbar disc prolapse. However, most
of those patients could only empty their bladder by straining or
changing the voiding posture postoperatively.68
LUTSs have been observed in patients with radiation myelop-
athy and Brown-Séquard syndrome (Table 2).69,70 LUTSs have also
been described as a result of brainstem encephalitis and viral sacral
myeloradiculitis following herpetic infection.71,72
5.8. Urodynamic study ﬁndings in patients with peripheral lesions
According to the number of nerves affected, peripheral
neuropathies can be classiﬁed as mononeuropathy, multiple
mononeuropathy and polyneuropathy. Themajor lesions that cause
peripheral neuropathies affect the axon (degeneration due to
toxicity, metabolic disease, etc.), the myelin sheath (demyelination
due to inﬂammatory diseases, hereditary diseases, etc.), or both the
axon and sheath (diabetes, etc.). Peripheral neuropathies can also
be classiﬁed into motor neuropathies (axonal type of Guillain-Barré
syndrome, etc.), sensory neuropathies (chronic sensory neurop-
athy, familial amyloid neuropathy, or Sjögren’s syndrome present-
ing as dorsal root ganglionitis), autonomic neuropathies (acute
pandysautonomia, etc.), and a combination of these.
Diabetes mellitus is the most common cause of small-ﬁber
neuropathies. Small-ﬁber involvement is usually part of a gener-
alized distal sensory neuropathy, but relatively independent
autonomic neuropathies do less commonly occur.41 The onset is
insidious over the course of several years, with progressive loss of
bladder sensation and impairment of bladder emptying due to
over-distention. UDSs demonstrate impaired detrusor contrac-
tility, a reduced urinary ﬂow rate, increased post-voiding residual
urine and reduced bladder sensation (diabetic cystopathy). In
a series of 84 patients with diabetes (58 males and 26 females
with a mean age of 60.8 years), diabetic cystopathy was observed
in 4% (average duration of diabetes of 143.5 months; hemoglobin
A1C of 7.7%). In addition to large post-voiding residual urine and
decreased sensations, OAB symptoms, detrusor over-activity and
increased bladder sensation were observed in 55%, 42% and 14%
of patients, respectively. On brain magnetic resonance imaging of
32 patients, multiple cerebral infarcts were observed in 76.5%
of those with detrusor over-activity. Therefore, both central and
peripheral mechanisms are involved in patients with diabetes.73
Although the most common ﬁnding on UDSs may be underac-
tive detrusor, detrusor over-activity is also reported to occur in
patients with peripheral neuropathies such as Guillain-Barré
syndrome and chronic inﬂammatory demyelinating poly-
radiculoneuropathy, probably due to peripheral nerve irritation or
ephaptic transmission.74,75
Peripheral nerves to the pelvic organs can be damaged by pelvic
surgery, such as resection of rectal carcinoma, radical prostatec-
tomy or radical hysterectomy. Damage to parasympathetic inner-
vation of the detrusor results in painless retention, poor urine
stream, loss of normal bladder sensation during ﬁlling and near loss
of detrusor contraction pressure (Figure 6). The primary cause of UI
after radical prostatectomy is sphincter insufﬁciency, but detrusor
over-activity, reduced bladder compliance and decreased contrac-
tility may also be relevant factors.76
Figure 6. Urodynamic ﬁndings in a patient after a radical hysterectomy who showed a low-compliance bladder (upper panel) and an acontractile detrusor (lower panel).
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Characteristic features of various types of lower urinary tract
symptoms, including urinary incontinence, bladder outlet
obstruction and neurogenic bladder, can be identiﬁed by UDSs.References
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